Diabetes-Related Cardiac Dysfunction
Lamario J. Williams (Williams LJ), Brenna G. Nye (Nye BG), Adam R. Wende (Wende AR)
Endocrinol Metab. 2017;32(2):171-179.   Published online 2017 Jun 23     DOI: https://doi.org/10.3803/EnM.2017.32.2.171
Citations to this article as recorded by Crossref logo
Protective effects of medicinal plant against diabetes induced cardiac disorder: A review
Sadegh Shabab, Zahra Gholamnezhad, Maryam Mahmoudabady
Journal of Ethnopharmacology.2021; 265: 113328.     CrossRef
Effect of Acute Chemotherapy on Glucose Levels in Rats
Ahmad H. Alhowail, Gena S. Alfawzan, Maha A. Aldubayan, Lolwah S. Alsalam
International Journal of Pharmacology.2020; 16(3): 276.     CrossRef
Transplantation of adipose tissue lacking PAI-1 improves glucose tolerance and attenuates cardiac metabolic abnormalities in high-fat diet-induced obesity
Sijing Liu, Yi Li, Xin Fan, Kai Li, Chunrong Xu, Liping Zhang, Mao Luo, Liqun Wang, Rong Li, Jianbo Wu
Adipocyte.2020; 9(1): 170.     CrossRef
Cardiometabolic-Based Chronic Disease, Adiposity and Dysglycemia Drivers
Jeffrey I. Mechanick, Michael E. Farkouh, Jonathan D. Newman, W. Timothy Garvey
Journal of the American College of Cardiology.2020; 75(5): 525.     CrossRef
Associated Targets of the Antioxidant Cardioprotection of Ganoderma lucidum in Diabetic Cardiomyopathy by Using Open Targets Platform: A Systematic Review
Fahmi Shaher, Hongbin Qiu, Shuqiu Wang, Yu Hu, Weiqun Wang, Yu Zhang, Yao Wei, Hisham AL-ward, Mahfoudh A. M. Abdulghani, Sattam Khulaif Alenezi, Salem Baldi, Shaobo Zhou
BioMed Research International.2020; 2020: 1.     CrossRef
Hyperbaric Oxygen Therapy Dampens Inflammatory Cytokine Production and Does Not Worsen the Cardiac Function and Oxidative State of Diabetic Rats
Rita Benkő, Zsuzsanna Miklós, Viktor Antal Ágoston, Katrine Ihonvien, Csaba Répás, Roland Csépányi-Kömi, Margit Kerék, Nóra Judit Béres, Eszter Mária Horváth
Antioxidants.2019; 8(12): 607.     CrossRef
Heart Failure in Type 2 Diabetes Mellitus
Helena C. Kenny, E. Dale Abel
Circulation Research.2019; 124(1): 121.     CrossRef
SGLT2 inhibition with empagliflozin improves coronary microvascular function and cardiac contractility in prediabetic ob/ob−/− mice
Damilola D. Adingupu, Sven O. Göpel, Julia Grönros, Margareta Behrendt, Matus Sotak, Tasso Miliotis, Ulrika Dahlqvist, Li-Ming Gan, Ann-Cathrine Jönsson-Rylander
Cardiovascular Diabetology.2019;[Epub]     CrossRef
Depressive symptoms in asymptomatic stage B heart failure with Type II diabetic mellitus
Paul J. Mills, Pam R. Taub, Ottar Lunde, Meredith A. Pung, Kathleen Wilson, Christopher Pruitt, Thomas Rutledge, Alan Maisel, Barry H. Greenberg
Clinical Cardiology.2019; 42(6): 637.     CrossRef
Pathophysiological mechanisms of diabetic cardiomyopathy and the therapeutic potential of epigallocatechin-3-gallate
Amir M. Al Hroob, Mohammad H. Abukhalil, Omnia E. Hussein, Ayman M. Mahmoud
Biomedicine & Pharmacotherapy.2019; 109: 2155.     CrossRef
The Janus face of HMGB1 in heart disease: a necessary update
Angela Raucci, Stefania Di Maggio, Francesco Scavello, Alessandro D’Ambrosio, Marco E. Bianchi, Maurizio C. Capogrossi
Cellular and Molecular Life Sciences.2019; 76(2): 211.     CrossRef
Histological evidence of chitosan-encapsulated curcumin suppresses heart and kidney damages on streptozotocin-induced type-1 diabetes in mice model
Sabri Sudirman, Ching-Shu Lai, Yi-Ling Yan, Hung-I Yeh, Zwe-Ling Kong
Scientific Reports.2019;[Epub]     CrossRef
Microarray profiling analysis identifies the mechanism of miR‐200b‐3p/mRNA‐CD36 affecting diabetic cardiomyopathy via peroxisome proliferator activated receptor‐γ signaling pathway
Liqiong Xu, Wei Chen, Min Ma, Anfang Chen, Chengyue Tang, Chengwei Zhang, Lin Cai
Journal of Cellular Biochemistry.2019; 120(4): 5193.     CrossRef
Plasma Low-Density Lipoprotein Cholesterol Correlates With Heart Function in Individuals With Type 2 Diabetes Mellitus: A Cross-Sectional Study
Po-Chung Cheng, Shang-Ren Hsu, Jung-Chi Li, Ching-Pei Chen, Szu-Chi Chien, Shih-Te Tu, Yun-Chung Cheng, Yu-Hsiu Liu, Jeng-Fu Kuo
Frontiers in Endocrinology.2019;[Epub]     CrossRef
Impact of diabetes mellitus on the contractile properties of the left and right atrial myofilaments†
Constanze Bening, Khaled Alhussini, Elena-Aura Mazalu, Jonathan Yaqub, Khaled Hamouda, Dejan Radakovic, Christoph Schimmer, Grzegorz Hirnle, Rainer Leyh
European Journal of Cardio-Thoracic Surgery.2018; 54(5): 826.     CrossRef
LAZ3 protects cardiac remodeling in diabetic cardiomyopathy via regulating miR-21/PPARa signaling
Lu Gao, Yuan Liu, Sen Guo, Lili Xiao, Leiming Wu, Zheng Wang, Cui Liang, Rui Yao, Yanzhou Zhang
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2018; 1864(10): 3322.     CrossRef
Gene expression profiles of rat MMECs with different glucose levels and fgl2 gene silencing
Zhenzhong Zheng, Fan Zhang, Dengpeng Gao, Yujing Wu, Hao Wu
Diabetes/Metabolism Research and Reviews.2018; 34(8): e3058.     CrossRef
Empagliflozin Ammeliorates High Glucose Induced-Cardiac Dysfuntion in Human iPSC-Derived Cardiomyocytes
Kwong-Man Ng, Yee-Man Lau, Vidhu Dhandhania, Zhu-Jun Cai, Yee-Ki Lee, Wing-Hon Lai, Hung-Fat Tse, Chung-Wah Siu
Scientific Reports.2018;[Epub]     CrossRef
Apelin‑13 ameliorates metabolic and cardiovascular disorders in a rat model of type 2 diabetes with a high‑fat diet
Meng Li, Huijuan Fang, Jian Hu
Molecular Medicine Reports.2018;[Epub]     CrossRef
Adriamycin-induced cardiomyopathy can serve as a model for diabetic cardiomyopathy – a hypothesis
Kaviyarasi Renu, V.G. Abilash, P.B. Tirupathi Pichiah, Thabassum Akthar Syeda, Sankarganesh Arunachalam
Asian Pacific Journal of Tropical Biomedicine.2017; 7(11): 1041.     CrossRef